The July edition of the Journal is now available online and includes: Venous thromboembolism and COCs: an ongoing saga This ongoing controversy recently resulted in the decision of the French authorities to withdraw the combined oral contraceptive (COC) containing ethinylestradiol (EE) and cyproterone acetate (i.e. Diane 35®) from the market. This consensus statement from 26 […]
Category: Clinical practice
New injectable – Sayana Press and Dianette VTE update
Sayana Press® is a progestogen-only injectable contraceptive licensed for subcutaneous use. It contains 104mg of medroxyprogesterone acetate (MPA) in 0.65ml suspension and is bioequivalent to IM depot medroxyprogesterone acetate. It is administered at intervals of 13 weeks +/- 7 days via a new delivery system (Unijet) – a single dose pre-filled injector. Although ideal for […]
Copenhagen Impressions
European Society of Contraception and Reproductive Health First Global Conference Highlights of the Congress included: Crown Princess Mary opening the Congress followed by the amazing Copenhagen drummers Green contraception – estrogen in water an issue, rating methods for their ‘greenness’: hormones, packaging etc. Lidegaard / Shulman / Dinger – continuing debate on […]
Online First articles
Use of UPA, LNG and the copper IUD for EC following the introduction of new FSRH guidelines This paper reports a notes review of emergency contraception (EC) prescription before and after the release of the Faculty guidelines in early 2012. It is interesting that Levonelle® remains a popular choice, possibly because there is less interference […]
DH Consultation on publication of abortion statistics
The Department of Health (DH) is proposing changes to the way it publishes abortion statistics for England and Wales, and is seeking the views of commissioners, clinicians, academics and other government departments and special interest groups. The consultation is open until 10 June 2013. The aim of the consultation is to ensure that the abortion […]
Help WHO revise its guidelines!
The WHO are currently preparing updates to its Medical Eligibility Criteria for Contraceptive Use and Selected Practice Recommendations for Contraceptive Use, which will be finalized in 2014, and are soliciting feedback from various stakeholders in the field of family planning to inform this process. The goal is to ensure these guidelines remain relevant to family planning […]
April Journal – 20th Anniversary of the FSRH
Hightlights from this edition include: The FSRH’s 20th anniversary It is 20 years since the establishment of the Faculty of Sexual and Reproductive Healthcare (FSRH). In celebrating its anniversary there is much to be proud of, and indeed Community Sexual and Reproductive Health is now a specialty in its own right. Readers should find the story […]
New RCN publication: Genital examination in women – A resource for skills development and assessment. The purpose of the document is to provide standards and sample assessment tools for training in genital examination in women for nurses working in sexual and reproductive health settings, and related health and social care settings. It replaces the earlier […]
Sexual health improvement framework, comments and other News
‘A Framework for Sexual Health Improvement in England’ sets out the government’s ambitions for improving sexual health. Designed to be used by local organisations when they are looking at how best to provide sexual health services in their area. This includes the need for: a fall in the number of unwanted pregnancies greater efforts to […]
Depo-Provera does not increase fracture risk.
Results from a new study published in the March issue of Obstetrics and Gynaecology demonstrate that the use of depot medroxyprogesterone acetate (DMPA) does not appear to increase fracture risk. Whilst the use of DMPA reduces serum oestrogen levels and is associated with significant loss of bone mineral density (BMD), this study shows that it […]